VRDN compared with CLDX: revenue, margins and what each company keeps, and the suppliers and customers both name

VRDNViridian Therapeutics, Inc.

Mkt capRevenueRevenue

CLDXCelldex Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

VRDNViridian Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 501dMethod ›

Moved together

VRDNwithCLDX

×0.34co-movement · CLDX on VRDN · 501d

r 0.40scale to r 0.75

Shared co-movers3with VRDNwith CLDX

DNLIDenali Therapeutics Inc.r 0.41r 0.48

NRIXNurix Therapeutics, Inc.r 0.36r 0.44

XNCRXencor Incr 0.34r 0.48

VRDN, solidCLDX, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

VRDNViridian Therapeutics, Inc.

24.69· pre 24.69· delayed

Mkt cap$2.8BRevenue$284,000Q2 FY26Revenue$71MFY25

CLDXCelldex Therapeutics, Inc.

30.10· pre 30.21

Pre-marketSep 2 '83

Mkt cap$2.4BRevenue$22,000Q2 FY26Revenue$7MFY24

Compare

Pre-marketSep 2 '83

VRDNViridian Therapeutics, Inc.

CLDXCelldex Therapeutics, Inc.

24.69pre 24.69delayed

Price

30.10pre 30.21

$2.8B

Mkt cap

$2.4B

Q2 FY26$284,000

Revenue

$22,000Q2 FY26

FY25$71M

Revenue

$7MFY24

VRDN24.69vsCLDX30.10Pre-marketSep 2 '83